Guidelines

The dEBM develops 'consensus-based' (S2) and 'evidence- and consensus-based' (S3/GRADE) guidelines. The dEBM was and is involved in national and international guideline projects.

You are here:

Ongoing guideline projects

  • Develop an evidence report for the update of the German evidence- and consensus-based guideline regarding the squamous cell carcinoma of the oral cavity
  • Development of evidence tables for the update of the German evidence- and consensus-based guideline regarding the prevention of melanoma
  • Methodical support of a consensus-based guideline on Psoriasis vulgaris in childhood and youth
  • Development of an German evidence- and consensus-based guideline on "Anal carcinoma"
  • Development of an German evidence- and consensus-based guideline on prevention of HPV associated neoplasia through vaccination
  • Adaptation of a German Zoster-guideline from the European Zoster-guideline

Finished guideline projects

  • Update of the international evidence- and consensus-based (GRADE) "Guideline for the Definition, Classification, Diagnosis and Management of Urticaria"
  • Update of the German evidence- and consensus-based (GRADE) guideline "Therapie der Psoriasis vulgaris"
  • Development of the German consensus-based guideline "Gebrauch von Präparationen zur lokalen Anwendung auf der Haut (Topika)"
  • Development of the evidence- and consensus-based guideline about epicutaneous testing
  • Methodical support for development of the consensus-based guideline for therapy of the chronic pruritus, published 2017 in JDDG
  • Update of the evidence- and consensus-based (GRADE) "European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.", published 2017 in JEADV
  • Development of the "European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis.", published 2017 in JEADV
  • Development of the "European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.", published 2017 in JEADV
  • Update of the European Evidence-based (S3) Guidelines for the Treatment of Acne, published 2016 in JEADV
  • Update of the evidence- and consensus-based (GRADE) "European S3-Guidelines on the systemic treatment of psoriasis vulgaris", published 2015 in JEADV
  • German evidence- and consensus-based "S3 guidelines for the management of anticoagulation in cutaneous surgery", published 2015 in JDDG
  • International evidence- and consensus-based (GRADE) "Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum", published 2015 in JEADV
  • German consensus-based guideline "for the therapy of pathological scars (hypertrophic scars and keloids)", published 2012 in JDDG
  • European Evidence-based (S3) Guidelines for the Treatment of Acne, published 2012 in JEADV
  • German evidence- and consensus-based guideline about squamous cell carcinoma of the oral cavity
  • Update German evidence- and consensus-based guideline on treatment of Psoriasis vulgaris, published 2011 in JDDG
  • German consensus-based Guideline "Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes", published 2011 in JDDG
  • German Consensus-based guideline for therapy of acne, published 2010 in JDDG
  • European evidence- and consensus-based guideline on treatment of Psoriasis vulgaris, published 2009 in JEADV
  • Update of the German evidence- and consensus-based "Guidelines for prophylactic vaccination against HPV-associated neoplasia", published 2009 in Vaccine
  • German evidence- and consensus-based guideline on prevention of HPV-associated neoplasm, published 2008 in Chemotherapie Journal
  • German evidence- and consensus-based guideline on treatment of Psoriasis vulgaris, published 2006 in JDDG